Theses
ldri | Bruxelles Woluwe
THESES IN PROGRESS
Auquière Marie
Encapsulation of lipids and microARNs in extracellular vesicles for the treatment of multiple sclerosis
Directors : Anne des Rieux and Giulio Muccioli
Cheng Chen
Metal-organic framework for oral antibody delivery for inflammatory bowel disease and colorectal cancer treatment
Director : Ana Beloqui Garcia
Debuisson Floriane
Mesenchymal stem cells delivery in hybrid spheroids for treatment of spinal cord injury: innovative formulation and pre-clinical perspectives.”
Director: Anne des Rieux (ADDB/LDRI)
Detroz Fanny
Development of nanomedicines to tackle cystic fibrosis lung disease
Directors Rita Vanbever and Mireille Dumoulin (ULiège)
Guilbaud Léo
Exploiting the cGAS-STING pathway as therapeutic target in inflammatory bowel disease treatment
Director: Ana Beloqui (ADDB/LDRI); Co-director: Alessio Malfanti (ADDB/LDRI)
Hendrickx Pauline
Programmable Biomaterials Laboratory/EPFL - Exploring the use of DNA nanotechnology for the cytoplasmic delivery of therapeutic miRNA for spinal cord injury repair
Director : Anne des Rieux
Hoflack Laurie
Development and pharmacological assessment of a dual nanocarrier containing pro-resolutive drugs in models of rheumatoid arthritis
Directors : Mireille Al Houayek and Ana Beloqui Garcia
Ladeiro Domingues Inês
Exploiting the biological effect exerted by nanocarriers in non-alcoholic fatty liver disease treatment.
Director: Ana Beloqui (ADDB/LDRI); Co-Director: Isabelle Leclercq (GAEN/IREC)
Lemaire Lorine
Design of an anti-elastase nanomedicine to prevent the evolution of emphysema in chronic obstructive pulmonary disease
Director: Rita Vanbever (ADDB/LDRI)
Leone Giuditta
Design of a long-acting vasodilator nanomedicine for inhalation in pulmonary arterial hypertension.
Director: Rita Vanbever (ADDB/LDRI) - Co-Director: Raphaël Frédérick (CMFA/LDRI)
Ma Zhanjun
Taking the best of two worlds to treat spinal cord injury: traditional Chinese medicine Rosmarinic acid combined with stem cell derived-extracellular vesicles
Director : Anne des Rieux
Marotti Valentina
Gene silencing of TNFα in inflammatory bowel disease treatment through a dual-shielding strategy via bioadhesive beads”.
Director: Ana Beloqui (ADDB/LDRI); Co-Director: Alessio Malfanti (ADDB/LDRI)
Parrens Paul
Engineering bacterocin-based nanomedicines for the eradication of Staphylococcus aureus intracellular reservoirs in the context of skin chronic infections
Director: Rita Vanbever (ADDB/LDRI); Co-director: Françoise Van Bambeke (TFAR FACM/LDRI)
Redeghieri Paola
Nanobodies to target proteases involved in inflammatory diseases of the lungs
Director: Mireille Dumoulin (Center for protein engineering, ULiège); Co-Director: Rita Vanbever (ADDB/LDRI)
Rodella Giulia
Design of hyaluronic acid-based chemo-immunotherapy for glioblastoma treatment
Directors: Alessio Malfanti (ADDB/LDRI) and Bernard Gallez (REMA/LDRI)
Van den Bossche William
Gas-promoted microbubbles-based drug delivery systems for the delivery of biologics in inflammatory bowel disease treatment
Director: Ana Beloqui (ADDB/LDRI)
Yang Jingjing
Development of rationally-designed stimuli-responsive nanoparticles for neuroprotective purposes in spinal cord injury repair
Directors : Anne des Rieux and Giulio Muccioli